SG11201406970QA - Methods for the synthesis of ethylfumarates and their use as intermediates - Google Patents

Methods for the synthesis of ethylfumarates and their use as intermediates

Info

Publication number
SG11201406970QA
SG11201406970QA SG11201406970QA SG11201406970QA SG11201406970QA SG 11201406970Q A SG11201406970Q A SG 11201406970QA SG 11201406970Q A SG11201406970Q A SG 11201406970QA SG 11201406970Q A SG11201406970Q A SG 11201406970QA SG 11201406970Q A SG11201406970Q A SG 11201406970QA
Authority
SG
Singapore
Prior art keywords
ethylfumarates
intermediates
synthesis
methods
Prior art date
Application number
SG11201406970QA
Other languages
English (en)
Inventor
Kelly Kraft
John Freeman
Paul Serwinski
Vinnie Pavia
Otto Phantsiel
Navneet Kaur
Original Assignee
Mannkind Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mannkind Corp filed Critical Mannkind Corp
Publication of SG11201406970QA publication Critical patent/SG11201406970QA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C07D241/08Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C201/00Preparation of esters of nitric or nitrous acid or of compounds containing nitro or nitroso groups bound to a carbon skeleton
    • C07C201/06Preparation of nitro compounds
    • C07C201/12Preparation of nitro compounds by reactions not involving the formation of nitro groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/30Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/39Preparation of carboxylic acid esters by oxidation of groups which are precursors for the acid moiety of the ester

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SG11201406970QA 2012-04-27 2013-03-15 Methods for the synthesis of ethylfumarates and their use as intermediates SG11201406970QA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261639536P 2012-04-27 2012-04-27
PCT/US2013/032162 WO2013162764A1 (en) 2012-04-27 2013-03-15 Methods for the synthesis of ethylfumarates and their use as intermediates

Publications (1)

Publication Number Publication Date
SG11201406970QA true SG11201406970QA (en) 2014-11-27

Family

ID=49477848

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201406970QA SG11201406970QA (en) 2012-04-27 2013-03-15 Methods for the synthesis of ethylfumarates and their use as intermediates

Country Status (16)

Country Link
US (5) US9193691B2 (es)
EP (1) EP2841422B1 (es)
JP (1) JP6241682B2 (es)
KR (1) KR20150023315A (es)
CN (2) CN107879938A (es)
AU (2) AU2013252901B2 (es)
BR (1) BR112014026809A2 (es)
CA (1) CA2871126C (es)
HK (1) HK1207382A1 (es)
IL (1) IL235247A0 (es)
IN (1) IN2014DN09774A (es)
MX (1) MX361470B (es)
RU (1) RU2014143116A (es)
SG (1) SG11201406970QA (es)
WO (1) WO2013162764A1 (es)
ZA (1) ZA201408429B (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
DE60318938T2 (de) 2002-03-20 2009-01-22 Mannkind Corp., Valencia Inhalationsgerät
EP1786784B1 (en) 2004-08-20 2010-10-27 MannKind Corporation Catalysis of diketopiperazine synthesis
CA2578175C (en) 2004-08-23 2014-10-14 Mannkind Corporation Diketopiperazine salts, diketomorpholine salts or diketodioxane salts for drug delivery
US7803404B2 (en) 2005-09-14 2010-09-28 Mannkind Corporation Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces
BRPI0707991B8 (pt) 2006-02-22 2021-05-25 Mannkind Corp métodos de preparação de um medicamento em pó seco com uma propriedade farmacêutica melhorada, dito pó seco e uso de uma quantidade efetiva do pó seco
EP2570147B1 (en) 2008-06-13 2017-10-18 MannKind Corporation A dry powder inhaler and system for drug delivery
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
US9364619B2 (en) 2008-06-20 2016-06-14 Mannkind Corporation Interactive apparatus and method for real-time profiling of inhalation efforts
TWI614024B (zh) 2008-08-11 2018-02-11 曼凱公司 超快起作用胰島素之用途
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
PL2405963T3 (pl) 2009-03-11 2014-04-30 Mannkind Corp Urządzenie, układ i sposób pomiaru oporu inhalatora
KR20180079458A (ko) 2009-06-12 2018-07-10 맨카인드 코포레이션 한정된 비표면적을 갖는 디케토피페라진 마이크로입자
EP2496295A1 (en) 2009-11-03 2012-09-12 MannKind Corporation An apparatus and method for simulating inhalation efforts
RU2531455C2 (ru) 2010-06-21 2014-10-20 Маннкайнд Корпорейшн Системы и способы доставки сухих порошковых лекарств
CN105667994B (zh) 2011-04-01 2018-04-06 曼金德公司 用于药物药盒的泡罩包装
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
AU2012328885B2 (en) 2011-10-24 2017-08-31 Mannkind Corporation Methods and compositions for treating pain
KR20150023315A (ko) * 2012-04-27 2015-03-05 맨카인드 코포레이션 에틸푸마레이트의 합성방법 및 중간체로서의 이들의 용도
CN108057154B (zh) 2012-07-12 2021-04-16 曼金德公司 干粉药物输送系统和方法
US10159644B2 (en) 2012-10-26 2018-12-25 Mannkind Corporation Inhalable vaccine compositions and methods
CA2906817C (en) 2013-03-15 2022-01-18 Mannkind Corporation Microcrystalline diketopiperazine compositions and methods
US9925144B2 (en) 2013-07-18 2018-03-27 Mannkind Corporation Heat-stable dry powder pharmaceutical compositions and methods
JP2016530930A (ja) 2013-08-05 2016-10-06 マンカインド コーポレイション 通気装置及び方法
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3407203A (en) 1965-03-22 1968-10-22 Union Carbide Corp Novel process for the preparation of diketopiperazines
US5352461A (en) * 1992-03-11 1994-10-04 Pharmaceutical Discovery Corporation Self assembling diketopiperazine drug delivery system
DE10019879A1 (de) 2000-04-20 2001-10-25 Degussa Verfahren zur Herstellung von 2,5-Diketopiperazinen, neue 2,5-Diketopiperazine und deren Verwendung
EP1786784B1 (en) 2004-08-20 2010-10-27 MannKind Corporation Catalysis of diketopiperazine synthesis
CA2578175C (en) 2004-08-23 2014-10-14 Mannkind Corporation Diketopiperazine salts, diketomorpholine salts or diketodioxane salts for drug delivery
BRPI0707991B8 (pt) * 2006-02-22 2021-05-25 Mannkind Corp métodos de preparação de um medicamento em pó seco com uma propriedade farmacêutica melhorada, dito pó seco e uso de uma quantidade efetiva do pó seco
WO2010078373A1 (en) * 2008-12-29 2010-07-08 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US8314106B2 (en) * 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
WO2010127452A1 (en) * 2009-05-04 2010-11-11 The Royal Institution For The Advancement Of Learning/Mcgill University 5-oxo-ete receptor antagonist compounds
CN101851213A (zh) * 2010-06-21 2010-10-06 于清 3,6-双(4-双反丁烯二酰基氨丁基)-2,5-二酮哌嗪及其盐取代物的合成方法
EP2673265B1 (en) 2011-02-10 2016-10-19 MannKind Corporation Formation of n-protected bis-3,6-(4-aminoalkyl) -2,5,diketopiperazine
KR20150023315A (ko) * 2012-04-27 2015-03-05 맨카인드 코포레이션 에틸푸마레이트의 합성방법 및 중간체로서의 이들의 용도

Also Published As

Publication number Publication date
US11479535B2 (en) 2022-10-25
JP6241682B2 (ja) 2017-12-06
ZA201408429B (en) 2021-05-26
IN2014DN09774A (es) 2015-07-31
US20210114994A1 (en) 2021-04-22
IL235247A0 (en) 2014-12-31
US20190010131A1 (en) 2019-01-10
AU2018201397A1 (en) 2018-03-22
EP2841422B1 (en) 2019-08-28
JP2015519321A (ja) 2015-07-09
AU2018201397B2 (en) 2019-05-02
CA2871126A1 (en) 2013-10-31
US20160159753A1 (en) 2016-06-09
WO2013162764A1 (en) 2013-10-31
HK1207382A1 (en) 2016-01-29
US10858325B2 (en) 2020-12-08
US20130289278A1 (en) 2013-10-31
RU2014143116A (ru) 2016-06-20
EP2841422A1 (en) 2015-03-04
MX361470B (es) 2018-12-06
US9193691B2 (en) 2015-11-24
CN107879938A (zh) 2018-04-06
CA2871126C (en) 2020-07-14
US10071969B2 (en) 2018-09-11
MX2014013075A (es) 2015-08-14
KR20150023315A (ko) 2015-03-05
CN104797563A (zh) 2015-07-22
US20230057608A1 (en) 2023-02-23
CN104797563B (zh) 2017-12-15
AU2013252901A1 (en) 2014-11-06
AU2013252901B2 (en) 2017-11-30
BR112014026809A2 (pt) 2017-06-27
EP2841422A4 (en) 2016-04-13

Similar Documents

Publication Publication Date Title
HK1207382A1 (en) Methods for the synthesis of ethylfumarates and their use as intermediates
HRP20181628T1 (hr) Spojevi i postupci za njihovu upotrebu
EP2828275A4 (en) SYNTHESIS OF 3-O-FUCOSYLLACTOSE TYPE TRISACCHARIDE AND ITS INTERMEDIATES
HK1208439A1 (en) 5-azaindazole compounds and methods of use 5-
PL2931406T3 (pl) Sposób syntezy cu-ssz-13 w jednym naczyniu reakcyjnym
PT2875062T (pt) Processo de síntese de poliarilétercetonas
ZA201406082B (en) Use of ccr3-inhibitors
SG10201703051WA (en) Compounds and methods for the production of suckerin and uses thereof
PT2897937T (pt) Processo para a preparação de indacaterol e de intermediários do mesmo
EP2691396A4 (en) ENOPEPTINES, USES THEREOF, AND METHODS OF SYNTHESIZING THE SAME
EP2888227A4 (en) NEW PRODRUGS AND METHODS OF USE
GB201111630D0 (en) Novel compounds and their use
GB201218352D0 (en) Compounds and their synthesis
SI2576556T1 (sl) Postopek za sintezo karbonukleozida in intermediatov za uporabo v tem postopku
IL246258A0 (en) Synthesis of an enantiomer of progesterone and its intermediates
HK1219650A1 (zh) 對映黃體酮及其中間產物的合成
EP2857379A4 (en) PROCESS FOR SYNTHESIS OF CURCUMINE
HK1160777A1 (en) Novel use of neohesperidoside
GB201213726D0 (en) Novel compounds and their use
AU2012900651A0 (en) Compounds and methods of their use
AU2012900650A0 (en) Compounds and methods of their use